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Neural stem cells (NSCs) have the potential for differentiation into neurons known as a groundbreaking
therapeutic solution for central nervous system (CNS) diseases. To resolve the therapeutic efﬁciency of
NSCs, recent researchers have focused on the study on microRNA's role in CNS. Some micro RNAs have
been reported signiﬁcant functions in NSC self-renewal and differentiation through the post-
transcriptional regulation of neurogenesis genes. MicroRNA-Let7a (Let7a) has known as the regulator
of diverse cellular mechanisms including cell differentiation and proliferation. In present study, we
investigated whether Let7a regulates NSC differentiation by targeting the nuclear receptor TLX, which is
an essential regulator of NSC self-renewal, proliferation and differentiation. We performed the following
experiments: western blot analysis, TaqMan assay, RT-PCR, and immunocytochemistry to conﬁrm the
alteration of NSCs. Our data showed that let7a play important roles in controlling NSC fate determina-
tion. Thus, manipulating Let-7A and TLX could be a novel strategy to enhance the efﬁciency of NSC's
neuronal differentiation for CNS disorders.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
miRNAs as short noncoding RNAs that are approximately 22
nucleotides (nt) in length act as the regulator of the speciﬁc gene's
expression [1,2]. Several researches reported that miRNAs could
recognize a lot of targets, and could regulates many cellular pro-
cesses [3], the cellular homeostasis [3] and could act as the medi-
ation of cell fate decisions by controlling transcription regulators
[4]. Numerous miRNAs expressed in the central nervous system
(CNS) are dynamically controlled during neural differentiation of
stem cells, indicating a considerable contribution to neural function
[5,6]. Micro RNA Let-7A (Let7a) as a member of Let-7 miRNA family
that consists of 12 different members [7] has been reported the
highest expression in neural stem cells (NSCs) [8]. Let-7A induces
neuronal differentiation in NSCs by targeting Lin28A and Lin28B
[9e11] and contributes to the maintenance of the NSC self-renewal
[12,13]. Speciﬁcally, Let-7 has been known to target TLX as aYonsei University College of
Yonsei University, 50 Yonsei-
þ82 2 365 0700.
Inc. This is an open access article utranscription factor that is expressed in early embryonic develop-
ment and adult stem cell niches [14]. TLX is an important target in
neural development by regulating cell cycle progression in NSCs
[15] by recruiting histone deacetylases [16]. TLXmaintains stem cell
self-renewal and regulates the neurogenesis in the cortex [17]. In
in vivo study using TLX transgenic mouse, the overexpression of
TLX results in the increase of NSC self-renewal in the subventricular
zone (SVZ) [18]. One study reported that TLX activates Wnt
signaling to promote adult NSC proliferation and self-renewal [19].
Another study indicated that the TLX-positive cells in the hippo-
campal dentate gyrus are important in spatial learning and mem-
ory [20]. During the differentiation of adult NSCs, TLX has been
reported that it is downregulated by several members of the Let-7
family such as Let-7b [21]. For CNS development, Let-7b also reg-
ulates target genes related to the nuclear receptor TLX as the cell
cycle controller in NSCs [22]. Moreover, Let-7 suppresses the pro-
liferation of NSCs through TLX inhibition and promotes neural and
glial differentiation [22,23]. In present study, we focused on the
mechanisms of action of Let7a functional implications during the
transition from NSCs and neural progenitors to differentiated
neurons. Especially, we investigated that Let-7a has the potential as
TLX regulator resulting the neuronal differentiation and self-
renewal of NSCs.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. NSC primary culture
Pregnant ICR mice were euthanized to obtain cortex NSC pri-
mary cultures according to the method described by Gritti et al.
[24]. Embryonic pup brains were extracted from the ICR mice
(E13.5) and placed in a Petri dish containing Hank's balanced salt
solution (HBSS) (Gibco, Grand Island, NY, USA), and each cortex was
dissected andwashed 1e2 times with plain HBSS. After dissociating
the tissues, supernatants were transferred to a fresh tube and
centrifuged at 1000 g for 5min. Pellets were resuspended in NSC
basal media with a proliferation supplement (Stem Cell Technolo-
gies, CA, USA), 20 ng/mL epidermal growth factor (Invitrogen,
Carlsbad, CA, USA). The NSCs were plated on poly-D-lysine-treated
plastic ware at density of 2.5  104 cells/mL. After 3 days of culture,
the cells proliferated and formed primary neurospheres. The pri-
mary neurospheres were dissociated using Accumax (Sigma, St.
Louis, MO, USA) into single cells. The single cells were seeded in
culture plates precoated with 0.001% poly L ornithine (Sigma, St.
Louis, MO, USA). In the differentiation group, NSCs were cultured in
the differentiation media (Stem Cell Technologies, CA, USA), and
were incubated for 5 days. NSCs of 2e3 passages were used for
experiments [25].
2.2. miR-Let7A mimics and inhibitor treatment
Mimics and inhibitor of miRNA and siRNAwere purchased from
Ambion (Ambion, Austin, TX, USA) and they were negative control
(cat #, 4464058), positive control (cat#, 4464062), mmu-let-7a-5p
(cat#, 4464066), and Let7a inhibitor (cat#, 4464066; assay ID,
MH10050). For the transfection of RNA duplexes, a 20 nM ﬁnal
concentration in Opti-MEM of Let-7A miRNA mimics and Let7a
inhibitor, and each control for miRNA or siRNA was mixed with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in serum-free
media and incubated at room temperature (RT) for 10 min. The
mixture was then added at the time when the NSCs were sub-
cultured into the next passage (third passage) and incubated for
72 h to form a neurosphere resulting from proliferation or to
initiate differentiation. The cells were harvested to the transfection
for total protein or RNA extraction.
2.3. Reverse transcription-PCR (RT-PCR)
To examine the expression of TLX, SOX2, and c-Myc in NSCs, RT-
PCR was performed using each primer. Brieﬂy, samples were lysed
with Trizol reagent (Invitrogen, Carlsbad, CA, USA), and total RNA
was extracted according to the manufacturer's protocol. cDNA
synthesis from mRNA and sample normalization were performed.
PCRwas performed using the following thermal cycling conditions:
10 min at 95 C; 35 cycles of denaturing at 95 C for 15 s, annealing
for 30 s at 70 C, elongation at 72 C for 30 s; ﬁnal extension for
10 min at 72 C, and held at 4 C. PCR was performed using the
following primers (50 to 30); TLX: forward (F): GGC TCT CTA CTT CCG
TGG ACA, reverse (R): GTC AGT ATT CAT GCC AGA TAC AGC CAG TG,
SOX2 (F): CCC CCG GCG GCA ATA GCA, (R) TCG GCG CCG GGG AGA
TAC AT, c-Myc (F): TCA AGAGGC GAACAC ACA AC, (R): GGC CTT TTC
ATT GTT TTC CA, GAPDH (F): GGCATGGACTGTGGTCATGAG, (R):
TGCACCACCAACTGCTTAGC. PCR products were electrophoresed in
1.5% agarose gels and stained with ethidium bromide.
2.4. Real Time qRT-PCR (SYBR and TaqMan assay)
Total RNA was extracted from cells using the TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer'sinstructions. For quantitative analysis of miR-Let7-A, reverse tran-
scription (RT) was ﬁrst performed using TaqMan Micro RNA
Reverse Transcription kit (Takara, Otsu, Shiga, Japan) according to
manufacturer's instructions with total RNA at 10 ng. PCR reactions
were then performed according to manufacturer's instructions to
quantitate the expression levels of Let7a using TaqMan Universal
PCR Master Mix, No Amp Erase UNG (Applied Biosystems, Foster
City, CA,USA), and the PCR ampliﬁcationwas performed in ABI 7500
Real Time PCR (Bio Rad, Philadelphia, PA, USA). The PCR forward
and reverse primers for Let7awere 50-GCGCCTGAGGTAGTAGGTTG-
30 and 50-CAGT GCAGGGTCCGAGGT-30. The PCR forward and
reverse primers for U6 were 50-CTCGCTTCGGCAGCACATAT ACT-30
and 50-ACGCTTCACGAATTTGCG TGTC-30, respectively. The data
were uniformly normalized to the internal control U6 and the
relative expression levels were evaluated using the 2DDCt method.
All experiments were run in triplicate [26].
2.5. Western blot
The collected NSCs were homogenized in lysis buffer (1% Triton
X-100, 0.5% NP-40, 150 mM NaCl, 10 mM Tris, 1 mM Ethylene-di-
amine tetra acetic acid, 1 mM EGTA Ph 8.0. 0.2 mM sodium
orthovandate, 0.2 mMphenulmethulsulfonyl ﬂuoride, and protease
inhibitor cocktail) and centrifuged (12,000 rpm at 4 C) for 15 min.
Equal amounts of protein (20 ug) from the supernants were sepa-
rated on a 10% acrylamide gel ad proteins were electrophoretically
transferred onto nitrocellulose membranes. After blocking with
Tris-buffered saline with Tween-20 and incubated with primary
antibody at overnight. Primary antibodies used were anti-DCX
(1:2000, Millipore, Massachusetts, MA, USA), and anti-NeuN
(1:1000, Santa Cruz, Santa Cruz, CA, USA), b-actin (1:2000, Santa
Cruz, Santa Cruz, CA, USA). The membranes were incubated with
HRP-conjugated secondary antibodies. The blots were rinsed and
protein bands were visualized using an enhanced chem-
iluminescence detection system (Amersham, Pittsburgh, PA, USA).
2.6. Immunocytochemistry
To conﬁrm the differentiation of NSCs, NSCs after 7 DIV were
washed three times with PBS for immunostaining and were
blocked for 30 min. The NSCs were then incubated with primary
antibodies overnight at 4 C. The following primary antibodies
were used: anti-SOX2 (1:200, Millipore, Massachusetts, MA, USA),
anti-DCX (1:200, Millipore, Massachusetts, MA, USA), anti-GFAP
(1:200, Millipore, Massachusetts, MA, USA). After incubating the
NSCs with the primary antibodies, primary antibody was then
removed, and cells were washed 3 times for 3 min each with PBS.
Next, samples were incubated with Flurescein isothiocyanate-
conjugated donkey anti-goat (1:200, Jackson Immunoresearch,
West Grove, PA, USA), Rhodamine-conjugated goat anti-rabbit
(1:200, Jackson Immunoresearch, West Grove, PA, USA), Textas
red-conjugated donkey anti-mouse (1:200, Jackson Immunor-
esearch, West Grove, PA, USA) for 2 h at room temperature. The
NSCs were washed again 3 times for 3 min each with PBS. The NSCs
were then counterstained with 1 mg/mL 40,6-diamidino-2-phenyl-
indole (DAPI) (1:100, Invitrogen, Carlsbad, CA, USA) for 10 min at
room temperature. Fixed samples were imaged using a Zeiss LSM
700 confocal microscope (Carl Zeiss, Thornwood, NY, USA).
2.7. Statistical analysis
Statistical analyses were carried out using SPSS 18.0 software
(IBM Corp., Armonk, NY, USA). All data are expressed as
mean ± S.E.M. Signiﬁcant intergroup differences were determined
by one-way analysis of variance followed by Bonferroni post hoc
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cates per condition. Differences were considered signiﬁcant at *
p < 0.05, **p < 0.001.
3. Results
To determine the alteration of proliferation and differentiation
related microRNA on NSCs, we measured the mRNA level of miR-9
and Let7a known as the microRNA regarding the cellular prolifer-
ation and differentiation using TaqMan assay (Fig. 1A). The
expression of miR-9 and Let7a were signiﬁcantly decreased in the
differentiation group which cultured in differentiation media
comparing with that in normal NSC culture media with a prolifer-
ation supplement. The transcriptional level of c-Myc and N-Myc has
been considered as the transcription factor regulating the cellular
proliferation and differentiation. Fig. 1B showed the relative
quantity of c-Myc and N-Myc mRNA during the differentiation of
NSC. In differentiation group, c-Myc and N-Myc mRNA levels were
signiﬁcantly observed higher than the normal group (Fig. 1B).
Fig. 1C showed that the alterations of neurospheres under the
condition of Let7a overexpression and inhibition (Fig. 1C). The
neurospheres more seem to maintain on the media in the Let7a
mimic treatment group whereas the Let7a inhibitor group seems to
sink into the dish's bottom to differentiate (Fig. 1C). In addition, to
examine the expression of DCX and NeuN considered as the
neuronal cell markers, we conducted western blot analysis using
each antibody (Fig. 2A). In Let7a overexpression condition, we
determined that the protein level of DCX and NeuN were signiﬁ-
cantly reduced compared to the normal control group (Fig. 2A).
Also, we conﬁrmed the immunoreactivity of SOX2, DCX (Fig. 2B),
GFAP (Fig. 2C) on NSCs under Let7a overexpression condition
(Fig. 2B and C). Our images showed that the NSCs in Let7a over-
expression state were attenuated the expression of DCX as
neuronal cell marker (Fig. 2B and C). To investigate the involvement
between Let7a and TLX reported as the NSC proliferation related
transcription factor, we measured the mRNA level of TLX in the
Let7a over-expression group and Let7a inhibition group (Fig. 3A
and B). By treating negative and positive miRNA mimic onto NSC,
any alteration of TLX or SOX2 was not detected. In the Let7a over-
expression group, TLX expression level was quite higher than theFig. 1. The alteration of miRNAs level in neural stem cells and its effect (A) TaqMan assay
Myc was evidently increased in the Let7a overexpression group compared with the norm
condition, over-expressing Let7a, and under-expressing Let-7a under bright ﬁeld microscopcontrol (Fig. 3A), while TLX expression level was signiﬁcantly
reduced in the Let7a inhibitor treatment group (Fig. 3B). The
expression of SOX2 which considered as the neural stem cell
marker was indicated the opposite patterns between the Let7a
over-expression group and the TLX inhibition group each. The
expression of c-Myc on NSCs was observed considerably increased
mRNA level than the other groups (Fig. 3C). The increased tran-
scriptional expression of c-Myc in the Let7a over-expression group
was counter-correlated in the Let7a inhibition group (Fig. 3C).
4. Discussion
In our study, we focused on the involvement of Let7a in NSC
proliferation and differentiation, and some ﬁndings and suggestion
are provided (/submitted) as follow: Let7a involves in mainly NSC
differentiation rather than proliferation (Fig. 2). According to the
Let7a level, expression level of TLX, SOX2, and c-Myc are positively
regulated (Fig. 3). Let7a involves in neuronal differentiation relating
with TLX at least partially. Multiple miRNAs have an important role
in NSC proliferation and differentiation. Let-7a is one of the lethal-7
miRNA family members which have been identifying and charac-
terizing [27,28]. In CNS, Let-7a has been elucidated to regulate the
neuronal differentiation during brain development [27]. Among in
various regulatory feedbacks between miRNA and its target genes,
Let-7 family and miR-9 is reported to target TLX which plays a role
in NSC self-renewal. For CNS development, Let-7b also regulates
target genes related to the nuclear receptor TLX as the cell cycle
controller in NSCs [22]. Moreover, Let-7 suppresses the prolifera-
tion of NSCs through TLX inhibition and promotes neural and glial
differentiation [22,23]. While the TLX regulation relating with
miRNAs has been reported in miR-9, miR-137, Let7b, and Let7d,
there are little reports to elucidate the feedback between let7a and
TLX in NSC proliferation and differentiation.
Besides of Let7a, we selected some miRNAs, TaqMan assay was
performed with relatively well-known brain-speciﬁc miRNA, miR-
9, miR-124, and miR-137. As previous mentioned reports, miR9
and Let7a level was signiﬁcantly changed (Fig. 1). Let7a over-
expression triggered increasing both of c-Myc and N-Myc tran-
scriptional level. The c-Myc, oncoprotein, has been recently
described to regulate stem cells by relating malignant cancer andwas performed for Let7a and miR-9. (B) In differentiation media, the mRNA level of c-
al group. (C) The morphology of neurosphere in NSC was changed by differentiating
e. NC, no treatment; Let7A, Let7A mimic; Differentiation, differentiation media.
Fig. 2. The effect of Let-7a on Proliferation and differentiation of NSC (A)Western blotting showed that the relative protein level of DCX and NeuN considerably was reduced in
the Let7A overexpression group compared to the normal control (NC) group. The bar graph shows the quantiﬁcation of DCX and NeuN protein in all groups. (B) Immunostained
images showed that SOX2-positive cells (red) were densely expressed in the Let7a overexpression group. In Let7a overexpression group, DCX expression (green) was a little bit
expressed in NSCs compared with the normal group. (C) Immunochemical images showed that little SOX2-positive cells changed in two groups, whereas GFAP (red) expression was
a little bit expressed in NSCs compared with the normal group in the Let7a overexpression group. *p < 0.05, **p < 0.001. Scale bar ¼ 200 mm, NC, normal control; Let7a, Let7a mimic.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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in mouse astroglia induces tumor, and the mass faster divides in c-
Myc expression group than in the c-Myc down-expression group
[30]. In agreement with previous reports, c-Myc as well as N-Myc
mRNA showed much higher level in Let7a overexpression group.
And it implicated that NSCs remained in proliferation level by Let7a
over-expression, in coincidently differentiation of NSC was
restrained. It was also detected the morphological change of neu-
rosphere supposing the each NSC processing stage, which was
affected by Let7a expression level. In the Let7a overexpression
group, the size of neurospheres was reduced compared to the
normal group (NC), but was not relatively small size ofneurospheres compared to the differentiation group (Fig. 1). It
could be conﬁrmed by western blot and immunocytochemistry
with neuronal marker and astrocyte marker (Fig. 2). The SOX2
stained images did not show difference between non-treated NSC
(NC) and Let7a overexpressing NSC, which noted that manipulating
Let7a level might be irrelevant to NSC proliferation. Rather, DCX-
positive cells in Let7a overexpressing NSC showed apparent
decrease contrast to NC. GFAP stained astrocyte was similar pattern
of DCX staining result (Fig. 2). It is apparent that Let7a involved in
NSC differentiation but it is unclear that Let7a regulate the mainly
transition of NSC to neuron or to non-neuronal lineage in this study
at least.
Fig. 3. The NSC differentiation under regulation of Let7a and the involvement of TLX in NSC differentiation (A) The mRNA level of TLX and SOX2 was increased in the Let7a
over-expression group. (B) The mRNA level of TLX and SOX2 was decreased in the Let7a inhibition group compared to the normal control group. (C) The mRNA level of c-Myc was
highly regulated by Let7a over-expressing, but its level in Let7a inhibition group was reduced comparing to the Let7a overexpression group. The bar graph shows the relative
quantiﬁcation of c-Myc mRNA in all groups. GAPDH was used as an internal control. Data are expressed as mean ± S.E.M. (*p < 0.05, **p < 0.001). Control, normal control; Let7a,
Let7a mimic, anti-Let7a: Inhibition of Let7a.
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differentiation of NSC vice versa let7a lowering NSC promotes
neuronal differentiation. Generally miRNAs negatively regulate by
binding the 30 untranslated region (UTR) of target mRNAs [31]. TLX
regulated by miRNA containing miR-9 plays an important role in
NSC activation and proliferation. However, the decrease of miR-9
can be rescued by up-regulated TLX, and it was suggested the
negative feedback regulation between miR-9 and TLX [32]. The
changing level of TLX transcript in our study was examined and the
TLX expression level was increased according to higher Let7a
expression level. With reverse corresponding to it, Let7a inhibition
was signiﬁcantly reduced more under the control level. In addition,
SOX2 expression was similar pattern with TLX that Let7a over-
expression led SOX2 increase and Let7a inhibition led it decrease.
On the other hand, c-Myc was one of genes targeted by Let7a some
threshold level of c-Mcy is needed to sustain the immortality of
cancer cells [33] or stem cells [29]. Recently c-Myc was reported to
be controlled by Let7 family containing Let7a. When c-Myc was
down-regulating, cellular proliferationwas hindered. Recent reportshowed the relationship in bladder cancer that Let7a regulates c-
Myc by participating Lin28/Let7a/c-Myc pathway in the cancer
progression [34]. Although the regulating loop was elucidated and
delineated in activating or maintain the cell proliferation, most of
studies are in endowing the immortality on cancer cell. Most of
studies focused on the cellular regulation under cancerous condi-
tion such as tumor proliferation cancer cell. This study however
provides the regulating role of Le7a in NSC proliferation and dif-
ferentiation mediating c-Myc along with TLX and SOX2 which are
relatively often suggested. In conclusion, present study showed
that neuronal differentiation of NSC is negatively regulated by over-
expressed Let7a relating with TLX. It could suggest that manipu-
lating Let7a may identify potential interventions with CNS diseases
and also propose future therapeutic directions for CNS disorders.
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